We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+22.86%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$16B
AUM Growth
+$2.39B
Cap. Flow
-$371M
Cap. Flow %
-2.31%
Top 10 Hldgs %
24.43%
Holding
979
New
49
Increased
147
Reduced
723
Closed
36

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$101M
2
ALC icon
Alcon
ALC
+$87.1M
3
OTIS icon
Otis Worldwide
OTIS
+$68.8M
4
MRSH
Marsh
MRSH
+$50M
5
MRK icon
Merck
MRK
+$49.8M

Top Sells

Rank Stock Value
1
RTN
Raytheon Company
RTN
+$56M
2
JPM icon
JPMorgan Chase
JPM
+$42.7M
3
AMZN icon
Amazon
AMZN
+$38.8M
4
AGN
Allergan plc
AGN
+$36.5M
5
MSFT icon
Microsoft
MSFT
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 22.31%
2 Healthcare 14.18%
3 Financials 13.68%
4 Consumer Discretionary 11.52%
5 Communication Services 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STZ icon
76
Constellation Brands
STZ
$22.5B
$51.7M 0.32%
295,584
+50,073
+20% +$8.34M
PLD icon
77
Prologis
PLD
$136B
$51.6M 0.32%
552,889
-9,574
-2% -$854K
LLY icon
78
Eli Lilly
LLY
$1.09T
$50.6M 0.32%
308,109
-8,345
-3% -$1.28M
AMGN icon
79
Amgen
AMGN
$210B
$50.5M 0.31%
214,183
-8,525
-4% -$1.95M
QCOM icon
80
Qualcomm
QCOM
$169B
$50.1M 0.31%
548,873
+283,168
+107% +$22.7M
EW icon
81
Edwards Lifesciences
EW
$49B
$46.6M 0.29%
674,103
+3,258
+0.5% +$232K
TXN icon
82
Texas Instruments
TXN
$250B
$46.2M 0.29%
363,810
-214,999
-37% -$25.1M
AJG icon
83
Arthur J. Gallagher & Co
AJG
$68.9B
$43.9M 0.27%
450,261
-53,344
-11% -$4.72M
SPGI icon
84
S&P Global
SPGI
$123B
$43.2M 0.27%
131,030
-11,010
-8% -$3.31M
MSI icon
85
Motorola Solutions
MSI
$72.6B
$43.1M 0.27%
307,434
+243,709
+382% +$34.5M
COR
86
DELISTED
Coresite Realty Corporation
COR
$42.8M 0.27%
353,236
-16,799
-5% -$2.02M
MU icon
87
Micron Technology
MU
$880B
$42.1M 0.26%
817,275
-4,526
-0.6% -$213K
BDX icon
88
Becton Dickinson
BDX
$46.4B
$41.3M 0.26%
177,132
-117,537
-40% -$28.3M
IQV icon
89
IQVIA
IQV
$40.3B
$39.8M 0.25%
280,429
+18,960
+7% +$2.57M
IBM icon
90
IBM
IBM
$214B
$39.1M 0.24%
338,264
-13,202
-4% -$1.53M
ARE icon
91
Alexandria Real Estate Equities
ARE
$9.41B
$37.4M 0.23%
230,406
+24,417
+12% +$3.73M
DHR icon
92
Danaher
DHR
$140B
$36.9M 0.23%
235,500
-39,078
-14% -$5.61M
COP icon
93
ConocoPhillips
COP
$144B
$35.4M 0.22%
841,970
+48,072
+6% +$1.94M
BSX icon
94
Boston Scientific
BSX
$68.6B
$35.2M 0.22%
1,003,873
+680,778
+211% +$24.5M
LOW icon
95
Lowe's Companies
LOW
$122B
$34.5M 0.21%
254,956
-19,654
-7% -$2.24M
INTU icon
96
Intuit
INTU
$90.3B
$33.7M 0.21%
113,792
+26,104
+30% +$7.16M
TJX icon
97
TJX Companies
TJX
$179B
$33.5M 0.21%
663,300
-24,826
-4% -$1.25M
SBUX icon
98
Starbucks
SBUX
$118B
$33.3M 0.21%
452,380
-21,577
-5% -$1.62M
SHOP icon
99
Shopify
SHOP
$169B
$33.1M 0.21%
350,210
+1,080
+0.3% +$75K
GILD icon
100
Gilead Sciences
GILD
$166B
$32.3M 0.2%
419,724
-28,878
-6% -$2.21M

Similar funds

Aviva's Q2 2020 Portfolio in Review

As of Q2 2020, Aviva held 979 positions worth $16B, up 18% from $13.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Aviva's Q2 2020 filing shows 49 new, 147 increased, 723 reduced and 36 closed positions. Its largest new stake was Otis Worldwide: 1,327,192 shares worth $75.5M. The largest sale was Raytheon Company, an estimated $56M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Aviva's largest Q2 2020 buy was Otis Worldwide: 1,327,192 shares worth $75.5M.
  • Aviva added most to Union Pacific in Q2 2020, an estimated $101M increase.
  • Aviva's biggest Q2 2020 reduction was JPMorgan Chase, cutting an estimated $42.7M.
  • Aviva fully exited Raytheon Company in Q2 2020, selling an estimated $56M.
  • Aviva's ten largest holdings make up 24% of its $16B portfolio in Q2 2020.
  • Aviva opened 49 new positions and closed 36 in Q2 2020.
  • Aviva's portfolio value rose 18% quarter-over-quarter to $16B.

Based on Aviva's 13F filing for Q2 2020, filed 13 Aug 2020.